25/07/2024
Quality-assured analysis of PIK3CA mutations in HR+/HER2- breast cancer tissue – A story about the need for proficiency testing for high-quality molecular biomarker reporting in precision medicine. Authors from FAU Erlangen-Nürnberg, BZKF, QuIP, Uniklinikum Erlangen, Philipps-Universität Marburg, Medizinische Hochschule Hannover/ MHHnova and Charité - Universitätsmedizin Berlin.
text: https://www.jmdjournal.org/article/S1525-1578(24)00088-6/fulltext